DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Kerlone (Betaxolol) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Kerlone (Betaxolol) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (16)
Disability (2)

Reports by Reaction Type

Renal Failure Acute (5)Intestinal Obstruction (5)Renal Failure (5)Dehydration (5)Drug Eruption (4)Adverse Drug Reaction (4)Fear (4)Fatigue (4)Overdose (4)Upper Respiratory Tract Infection (4)Abnormal Loss of Weight (4)Pancreatic Enzymes Increased (4)

Possible Kerlone side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-03

Patient: 60 year old male

Reactions: Hypotension, Shock, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kerlone
    Administration route: Oral
    Start date: 2012-06-13
    End date: 2012-06-29

Isoptin
    Administration route: Oral
    Start date: 2012-06-13
    End date: 2012-06-29



Possible Kerlone side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-13

Patient: 50 year old male

Reactions: Renal Failure, Amylase Increased, Dehydration, Condition Aggravated, Lipase Increased, Intestinal Obstruction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rilmenidine (Rilmenidine)
    Dosage: (1 mg qd oral)
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Kerlone
    Dosage: (20 mg qd oral) ; (df)
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Kerlone
    Dosage: (20 mg qd oral) ; (df)
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-08-20

Atorvastatin Calcium
    Dosage: (20 mg qd oral)
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Allopurinol
    Dosage: (300 mg qd oral)
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Lercanidipine
    Dosage: (20 mg qd oral)
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Novonorm (Novo-Norm-Ripaglinide) (Not Specified)
    Dosage: (3 mg tid oral) ; (df oral)
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Novonorm (Novo-Norm-Ripaglinide) (Not Specified)
    Dosage: (3 mg tid oral) ; (df oral)
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-08-19

Sitagliptin Phosphate
    Dosage: (50 mg qd oral)
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Enalapril Maleate and Hydrochlorothiazide
    Dosage: (once daily oral)
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Oxycodone HCL
    Dosage: (10 mg, frequency unknown oral)
    Administration route: Oral
    Indication: Back Pain
    Start date: 2011-07-13
    End date: 2011-08-09

Other drugs received by patient: Tacrolimus; Cellcept; Prednisone TAB



Possible Kerlone side effects in 33 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-06

Patient: 33 year old female, weighing 51.8 kg (114.0 pounds)

Reactions: Drug Eruption, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Omeprazole
    Indication: Gastritis Prophylaxis
    End date: 2011-04-18

Amlodipine Besylate
    Indication: Hypertension
    End date: 2011-04-18

Rasilez (Aliskiren) (Aliskiren)
    Indication: Hypertension
    End date: 2011-04-18

Olmesartan Medoxomil
    Indication: Hypertension
    End date: 2011-04-18

Trichlormethiazide
    Indication: Hypertension
    End date: 2011-04-18

Lasix
    Indication: Hypertension
    End date: 2011-04-18

Kerlone
    Indication: Hypertension
    End date: 2011-04-18



Possible Kerlone side effects in 33 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-06

Patient: 33 year old female

Reactions: Drug Eruption, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kerlone
    Dosage: unk
    Indication: Hypertension
    End date: 2011-04-18

Trichlormethiazide
    Dosage: unk
    Indication: Hypertension
    End date: 2011-04-18

Olmesartan Medoxomil
    Dosage: unk
    Indication: Hypertension
    End date: 2011-04-18

Rasilez
    Dosage: unk
    Indication: Hypertension
    End date: 2011-04-18

Famotidine
    Dosage: unk
    Indication: Gastritis Prophylaxis
    End date: 2011-04-18

Lasix
    Dosage: unk
    Indication: Hypertension
    End date: 2011-04-18

Amlodipine
    Dosage: unk
    Indication: Hypertension
    End date: 2011-04-18



Possible Kerlone side effects in 33 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-01-23

Patient: 33 year old female

Reactions: Drug Eruption, Malaise, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Olmesartan Medoxomil
    Dosage: unk
    Administration route: Oral
    Indication: Hypertension
    End date: 2011-04-18

Lasix
    Dosage: unk
    Indication: Hypertension
    End date: 2011-04-18

Rasilez
    Dosage: unk
    Indication: Hypertension
    End date: 2011-04-18

Amlodipine
    Dosage: unk
    Administration route: Oral
    Indication: Hypertension
    End date: 2011-04-18

Kerlone
    Dosage: unk
    Indication: Hypertension
    End date: 2011-04-18

Famotidine
    Dosage: unk
    Indication: Gastritis Prophylaxis
    End date: 2011-04-18

Trichlormethiazide
    Dosage: unk
    Indication: Hypertension
    End date: 2011-04-18



Possible Kerlone side effects in 33 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-01-19

Patient: 33 year old female, weighing 51.8 kg (114.0 pounds)

Reactions: Drug Eruption, Fibromuscular Dysplasia, Malaise, Erythema, Renal Failure Acute, Renal Artery Stenosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kerlone
    Indication: Hypertension
    End date: 2011-04-18

Olmesartan Medoxomil
    Indication: Hypertension
    End date: 2011-04-18

Lasix
    Indication: Hypertension
    End date: 2011-04-18

Amlodipine Besylate
    Indication: Hypertension
    End date: 2011-04-18

Rasilez (Aliskiren) (Aliskiren)
    Indication: Hypertension
    End date: 2011-04-18

Trichlormethiazide
    Indication: Hypertension
    End date: 2011-04-18

Omeprazole
    Indication: Gastritis Prophylaxis
    End date: 2011-04-18



Possible Kerlone side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-27

Patient: female, weighing 81.7 kg (179.6 pounds)

Reactions: Wrong Technique in Drug Usage Process, Osteoporosis, Fear, Adverse Drug Reaction, Overdose, Fatigue, Medication Error, Upper Respiratory Tract Infection, Abnormal Loss of Weight, Depression, Kidney Infection, Nervousness, Decreased Appetite, Product Quality Issue, Psychomotor Hyperactivity, Abnormal Behaviour, Tremor, Convulsion, Anxiety, Arthralgia, Heart Rate Increased, Insomnia, Disturbance in Attention, DRY Eye, Asthenia, Feeling Abnormal, Accidental Exposure

Drug(s) suspected as cause:
Topiramate
    Administration route: Oral

Topiramate
    Administration route: Oral
    Start date: 2008-01-01

Topamax
    Administration route: Oral
    Start date: 2011-08-22

Topamax
    Administration route: Oral
    Start date: 2011-08-22

Topamax
    Administration route: Oral
    Start date: 2011-07-01

Topiramate
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-06-27

Topiramate
    Administration route: Oral
    Indication: Convulsion
    Start date: 2008-01-01

Topamax
    Administration route: Oral
    Start date: 2011-07-01

Topamax
    Administration route: Oral
    Indication: Migraine

Topamax
    Administration route: Oral
    Start date: 2011-06-27
    End date: 2011-07-01

Celexa
    Indication: Product Used FOR Unknown Indication

Trazodone Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-01-01

Topiramate
    Administration route: Oral
    Indication: Migraine Prophylaxis

Topiramate
    Administration route: Oral

Unknown Medication
    Indication: Product Used FOR Unknown Indication

Topiramate
    Administration route: Oral
    Indication: Migraine

Topamax
    Administration route: Oral
    Start date: 2001-01-26

Topiramate
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-06-27

Topamax
    Administration route: Oral
    Start date: 2011-06-27
    End date: 2011-07-01

Topiramate
    Administration route: Oral
    Indication: Migraine
    Start date: 2008-01-01

Kerlone
    Indication: Product Used FOR Unknown Indication
    Start date: 2001-01-26

Topiramate
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2011-01-01

Topiramate
    Administration route: Oral
    Start date: 2008-01-01

Topiramate
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2011-01-01

Topamax
    Administration route: Oral
    Indication: Convulsion

Topiramate
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2008-01-01

Topiramate
    Administration route: Oral

Topiramate
    Administration route: Oral

Topiramate
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2011-01-01

Topiramate
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-06-27

Topamax
    Administration route: Oral
    Start date: 2001-01-26



Possible Kerlone side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-21

Patient:

Reactions: Renal Failure, Dehydration, Intestinal Obstruction, Pancreatic Enzymes Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Repaglinide
    Dosage: unk
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2011-08-09

Lercanidipine
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Kerlone
    Dosage: 20 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Repaglinide
    Dosage: unk
    Administration route: Oral
    Start date: 2011-08-19

Rilmenidine
    Dosage: 1 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Allopurinol
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Januvia
    Dosage: 0.5 pharmaceutical dose daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Kerlone
    Dosage: unk
    Start date: 2011-08-20

Atorvastatin Calcium
    Dosage: 20 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Oxycontin
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-13
    End date: 2011-08-09

Other drugs received by patient: Tacrolimus; Cellcept; Prednisone



Possible Kerlone side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-19

Patient: female, weighing 81.7 kg (179.6 pounds)

Reactions: Wrong Technique in Drug Usage Process, Adverse Drug Reaction, Fear, Fatigue, Overdose, Upper Respiratory Tract Infection, Medication Error, Abnormal Loss of Weight, Nervousness, Decreased Appetite, Product Quality Issue, Psychomotor Hyperactivity, Convulsion, Tremor, Anxiety, Arthralgia, Heart Rate Increased, Insomnia, Disturbance in Attention, Asthenia, Feeling Abnormal, Accidental Exposure

Drug(s) suspected as cause:
Topiramate
    Administration route: Oral
    Indication: Migraine Prophylaxis
    Start date: 2008-01-01

Topiramate
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-06-27

Topiramate
    Administration route: Oral
    Indication: Migraine
    Start date: 2008-01-01

Unknown Medication
    Indication: Product Used FOR Unknown Indication

Topiramate
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2011-01-01

Topiramate
    Administration route: Oral
    Start date: 2008-01-01

Topamax
    Administration route: Oral
    Indication: Convulsion
    Start date: 2001-01-26

Topamax
    Administration route: Oral
    Start date: 2011-08-22

Topiramate
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2011-01-01

Celexa
    Indication: Product Used FOR Unknown Indication

Topiramate
    Administration route: Oral
    Start date: 2008-01-01

Topamax
    Administration route: Oral

Topamax
    Administration route: Oral

Topiramate
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2008-01-01

Topamax
    Administration route: Oral
    Start date: 2011-06-27
    End date: 2011-07-01

Topamax
    Administration route: Oral
    Start date: 2011-07-01

Topamax
    Administration route: Oral
    Start date: 2011-06-27
    End date: 2011-07-01

Trazodone Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-01-01

Topiramate
    Administration route: Oral
    Indication: Convulsion
    Start date: 2005-01-01
    End date: 2011-01-01

Topiramate
    Administration route: Oral
    Indication: Migraine
    Start date: 2011-01-01
    End date: 2011-06-27

Topamax
    Administration route: Oral
    Start date: 2001-01-26

Topiramate
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-06-27

Topamax
    Administration route: Oral
    Indication: Migraine
    Start date: 2011-08-22

Topamax
    Administration route: Oral
    Start date: 2011-07-01

Kerlone
    Indication: Product Used FOR Unknown Indication
    Start date: 2001-01-26



Possible Kerlone side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-19

Patient: 50 year old male

Reactions: Renal Failure, Dehydration, Pancreatic Enzymes Increased, Intestinal Obstruction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Atorvastatin Calcium
    Administration route: Oral
    End date: 2011-08-09

Enalapril Maleate and Hydrochlorothiazide
    Administration route: Oral
    End date: 2011-08-09

Januvia
    Administration route: Oral
    End date: 2011-08-09

Rilmenidine
    Administration route: Oral
    End date: 2011-08-09

Kerlone
    Administration route: Oral
    End date: 2011-08-09

Lercanidipine
    Administration route: Oral
    End date: 2011-08-09

Repaglinide
    Administration route: Oral
    End date: 2011-08-09

Allopurinol
    Administration route: Oral
    End date: 2011-08-09

Oxycontin
    Administration route: Oral
    Start date: 2011-07-13
    End date: 2011-08-09



Possible Kerlone side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-13

Patient: 50 year old male

Reactions: Renal Failure, Dehydration, Pancreatic Enzymes Increased, Intestinal Obstruction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Atorvastatin Calcium
    Dosage: 20 mg, 1x/day
    Administration route: Oral
    End date: 2011-08-09

Januvia
    Dosage: 0.5 df, 1x/day
    Administration route: Oral
    End date: 2011-08-09

Repaglinide
    Dosage: 3 mg, 3x/day
    Administration route: Oral
    End date: 2011-08-09

Oxycontin
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Back Pain
    Start date: 2011-07-13
    End date: 2011-08-09

Rilmenidine
    Dosage: 1 mg, 1x/day
    Administration route: Oral
    End date: 2011-08-09

Allopurinol
    Dosage: 300 mg, 1x/day
    Administration route: Oral
    End date: 2011-08-09

Lercanidipine
    Dosage: 20 mg, 1x/day
    Administration route: Oral
    End date: 2011-08-09

Kerlone
    Dosage: 20 mg, 1x/day
    Administration route: Oral
    End date: 2011-08-09

Enalapril Maleate and Hydrochlorothiazide
    Dosage: 1 df, 1x/day
    Administration route: Oral
    End date: 2011-08-09

Other drugs received by patient: Mycophenolate Mofetil (Cellcept); Tacrolimus; Prednisone



Possible Kerlone side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-12

Patient: male

Reactions: Renal Failure, Dehydration, Intestinal Obstruction, Pancreatic Enzymes Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lercanidipine
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Atorvastatin Calcium
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Enalapril Maleate and Hydrochlorothiazide
    Dosage: 1 df, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Allopurinol
    Dosage: 300 mg, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Repaglinide
    Dosage: 3 mg, tid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Januvia
    Dosage: 0.5 df, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Rilmenidine
    Dosage: 1 df, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09

Oxycodone HCL
    Dosage: unk
    Administration route: Oral
    Indication: Pain
    Start date: 2011-07-13
    End date: 2011-08-09

Kerlone
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-09



Possible Kerlone side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-11

Patient: female, weighing 81.7 kg (179.6 pounds)

Reactions: Wrong Technique in Drug Usage Process, Adverse Drug Reaction, Fear, Overdose, Fatigue, Medication Error, Upper Respiratory Tract Infection, Abnormal Loss of Weight, Decreased Appetite, Nervousness, Product Quality Issue, Psychomotor Hyperactivity, Convulsion, Tremor, Anxiety, Arthralgia, Insomnia, Heart Rate Increased, Disturbance in Attention, Asthenia, Feeling Abnormal, Accidental Exposure

Drug(s) suspected as cause:
Topamax
    Administration route: Oral
    Start date: 2011-07-01

Topamax
    Administration route: Oral

Kerlone
    Indication: Product Used FOR Unknown Indication
    Start date: 2001-01-26

Topiramate
    Administration route: Oral
    Indication: Migraine
    Start date: 2011-01-01
    End date: 2011-06-27

Topiramate
    Administration route: Oral
    Start date: 2008-01-01

Topamax
    Administration route: Oral
    Start date: 2011-08-22

Topamax
    Administration route: Oral

Topamax
    Administration route: Oral
    Start date: 2001-01-26

Topiramate
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-06-27

Topiramate
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-06-27

Topiramate
    Administration route: Oral
    Indication: Migraine
    Start date: 2008-01-01

Unknown Medication
    Indication: Product Used FOR Unknown Indication

Topiramate
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2011-01-01

Topiramate
    Administration route: Oral
    Start date: 2008-01-01

Topamax
    Administration route: Oral
    Indication: Migraine
    Start date: 2011-08-22

Topamax
    Administration route: Oral
    Start date: 2011-07-01

Celexa
    Indication: Product Used FOR Unknown Indication

Trazodone Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-01-01

Topiramate
    Administration route: Oral
    Indication: Migraine Prophylaxis
    Start date: 2008-01-01

Topiramate
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2011-01-01

Topamax
    Administration route: Oral
    Start date: 2011-06-27
    End date: 2011-07-01

Topamax
    Administration route: Oral
    Start date: 2011-06-27
    End date: 2011-07-01

Topiramate
    Administration route: Oral
    Indication: Convulsion
    Start date: 2005-01-01
    End date: 2011-01-01

Topamax
    Administration route: Oral
    Indication: Convulsion
    Start date: 2001-01-26

Topiramate
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2008-01-01



Possible Kerlone side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-10

Patient: female, weighing 81.7 kg (179.6 pounds)

Reactions: Wrong Technique in Drug Usage Process, Fear, Adverse Drug Reaction, Fatigue, Overdose, Upper Respiratory Tract Infection, Medication Error, Abnormal Loss of Weight, Nervousness, Decreased Appetite, Product Quality Issue, Psychomotor Hyperactivity, Convulsion, Tremor, Anxiety, Arthralgia, Heart Rate Increased, Insomnia, Disturbance in Attention, Asthenia, Feeling Abnormal, Accidental Exposure

Drug(s) suspected as cause:
Topamax
    Administration route: Oral
    Indication: Convulsion
    Start date: 2001-01-26

Topamax
    Administration route: Oral
    Start date: 2011-06-27
    End date: 2011-07-01

Topiramate
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-06-27

Topiramate
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2011-01-01

Topiramate
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-06-27

Topamax
    Administration route: Oral
    Indication: Migraine
    Start date: 2011-08-22

Celexa
    Indication: Product Used FOR Unknown Indication

Trazodone Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-01-01

Topiramate
    Administration route: Oral
    Start date: 2008-01-01

Topiramate
    Administration route: Oral
    Indication: Migraine Prophylaxis
    Start date: 2008-01-01

Topiramate
    Administration route: Oral
    Indication: Migraine
    Start date: 2011-01-01
    End date: 2011-06-27

Topamax
    Administration route: Oral

Topamax
    Administration route: Oral
    Start date: 2011-07-01

Topiramate
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2008-01-01

Unknown Medication
    Indication: Product Used FOR Unknown Indication

Topamax
    Administration route: Oral
    Start date: 2001-01-26

Topiramate
    Administration route: Oral
    Indication: Migraine
    Start date: 2008-01-01

Topiramate
    Administration route: Oral
    Indication: Convulsion
    Start date: 2005-01-01
    End date: 2011-01-01

Topiramate
    Administration route: Oral
    Start date: 2008-01-01

Topamax
    Administration route: Oral
    Start date: 2011-08-22

Topamax
    Administration route: Oral
    Start date: 2011-06-27
    End date: 2011-07-01

Topamax
    Administration route: Oral
    Start date: 2011-07-01

Topamax
    Administration route: Oral

Kerlone
    Indication: Product Used FOR Unknown Indication
    Start date: 2001-01-26

Topiramate
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2011-01-01



Possible Kerlone side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-07

Patient: 68 year old female

Reactions: Pain, Muscular Weakness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Kerlone
    Administration route: Oral
    Start date: 2000-01-01
    End date: 2011-03-01

Crestor
    Administration route: Oral
    Start date: 2006-09-01
    End date: 2009-09-01

Kerlone
    Administration route: Oral
    Indication: Migraine
    Start date: 2000-01-01
    End date: 2011-03-01



Possible Kerlone side effects in 68 year old female

Reported by a physician from France on 2011-10-05

Patient: 68 year old female

Reactions: Pain, Muscular Weakness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Kerlone
    Administration route: Oral
    Indication: Hypertension
    Start date: 2000-01-01
    End date: 2011-03-01

Crestor
    Administration route: Oral
    Indication: Dyslipidaemia
    Start date: 2006-09-01
    End date: 2009-09-01

Kerlone
    Administration route: Oral
    Indication: Migraine
    Start date: 2000-01-01
    End date: 2011-03-01

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014